Today: 4 May 2026

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan stock today: FCX edges up as copper rebounds toward record highs

Freeport-McMoRan shares rose 0.5% to $51.75 Tuesday afternoon as copper futures rebounded 3.7% to $5.77 a pound. Copper hovered near record highs after touching $12,960 per ton Monday and is up 42% in 2025. Other major miners, including Southern Copper, BHP, and Rio Tinto, also gained in U.S. trading. Traders are watching if copper holds these levels into the new year.
30 December 2025
··
Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Why Karman Holdings Stock Is Down Today: KRMN Slides as Year-End Flows Hit Defense-Space Names

Karman Holdings shares fell 3.6% to $74.81 in New York afternoon trading Tuesday, underperforming the broader market after a $258.7 million outflow from the SPDR S&P Aerospace & Defense ETF. The stock touched a session low of $74.21, with about 465,000 shares traded. Investors are watching for signs of stabilization ahead of the company’s next quarterly update.
30 December 2025
··
CRH stock dips today as buyback rolls on and Fed minutes loom

CRH stock dips today as buyback rolls on and Fed minutes loom

CRH shares fell 1.1% to $126.01 in New York Tuesday after the company disclosed buying 31,100 shares Monday under its U.S. buyback program. The repurchases, part of a $300 million plan, came as markets traded in thin year-end conditions. Investors awaited Federal Reserve minutes due later in the day. Other U.S.-listed aggregates producers also slipped.
30 December 2025
·
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

Charles Schwab shares fell 0.6% to $100.69 in afternoon trading Tuesday, with rivals Interactive Brokers and Robinhood also lower. Investors awaited Federal Reserve minutes due later in the day for signals on rate policy. A regulatory filing showed Schwab executive Jonathan Beatty exercised options and a related trust sold 2,000 shares at about $102.01. Schwab’s fourth-quarter results are expected Jan. 21.
30 December 2025
·····
KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA stock dips as China’s 50% domestic chip-tool rule rattles semiconductor equipment names

KLA shares fell 0.8% to $1,250.43 Tuesday after a Reuters report said China will require chipmakers to source at least half of new-fab equipment domestically. U.S. chip-equipment stocks tracked lower as traders awaited Federal Reserve minutes and eyed tightening export-license rules. Applied Materials and Lam Research also declined, while ASML rose.
30 December 2025
······
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Arrowhead Pharmaceuticals shares fell 3.6% to $67.09 by early afternoon Tuesday, outpacing declines in biotech peers as traders positioned ahead of key January updates. The drop followed recent volatility after FDA approval of REDEMPLO, the company’s first commercial drug for familial chylomicronemia syndrome. Arrowhead plans to release interim obesity-program data and present at the J.P. Morgan Healthcare Conference in early January.
30 December 2025
··
Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo stock slips as Fed minutes loom in thin year-end trading

Wells Fargo shares fell 0.4% to $94.15 in afternoon New York trading Tuesday, tracking declines across U.S. bank stocks ahead of Federal Reserve meeting minutes. Investors focused on rate expectations for 2026 and the bank’s upcoming earnings in mid-January. The 10-year Treasury yield rose to 4.134% as financial sector ETFs also slipped in thin, year-end trading.
30 December 2025
···
Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer stock today: PFE edges up after TD Cowen sticks with Hold as investors size up 2026 outlook

Pfizer shares edged up 0.1% to $25.03 Tuesday after TD Cowen reiterated a Hold rating and $30 price target, citing negative trends through 2030. The company projected 2026 revenue of $59.5 billion to $62.5 billion and warned of a “bumpy” period ahead as COVID demand fades and key patents expire. Shares have dropped over 50% since early 2023. Pfizer’s next earnings report is set for February 3.
30 December 2025
··
Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

Natural gas price steadies near $4 as UNG stock climbs; traders await fresh U.S. storage data

United States Natural Gas Fund (UNG) rose 1.6% to $13.26 in midday trading Tuesday as February Henry Hub futures held above $4 per mmBtu. U.S. gas storage fell by 166 billion cubic feet to 3,413 bcf for the week ended Dec. 19. Traders await the EIA storage report due Wednesday at noon ET. Leveraged gas ETFs moved sharply, with BOIL up 2% and KOLD down 2%.
30 December 2025
···
Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels stock falls today as UUUU pulls back after uranium sales beat, new contracts

Energy Fuels Inc shares fell 3.5% to $14.55 in Tuesday afternoon trading, underperforming uranium peers. The company said it exceeded 2025 uranium production guidance and completed two new long-term sales contracts with U.S. nuclear power generators. Energy Fuels expects to sell 360,000 pounds of U3O8 in Q4 for about $27 million at a weighted average price of $74.93 per pound.
30 December 2025
··
1 … 916 917 918 919 920 … 1,894

Stock Market Today

  • Marvell Technology's Stock Surges 165% in 1 Year but Faces Overvaluation Concerns
    May 3, 2026, 7:46 PM EDT. Marvell Technology's shares have surged 165.4% over the past year amid strong market interest in its semiconductor position supporting AI and data center growth. Despite this rally, valuation metrics raise caution. A Discounted Cash Flow (DCF) model estimates intrinsic value at around $64.35 per share, well below the recent price of $164.95, suggesting the stock is overpriced by over 150% on this basis. Its Price-to-Earnings (P/E) ratio and other traditional valuation tools also point to overvaluation risks. Investors are weighing Marvell's growth potential against these stretched valuations as broader market themes continue to drive interest in semiconductor firms tied to AI infrastructure and cloud demand.

Latest article

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

Navitas Semiconductor Stock Is Running Hot. Tuesday Will Test the AI Power Story

4 May 2026
Navitas Semiconductor shares rose 5.76% to $17.45 Friday on heavy volume ahead of first-quarter results due Tuesday. The company forecast Q1 revenue of $8.0–$8.5 million after posting a $41.4 million loss last quarter. Management highlighted new high-power chips for AI data centers but warned that design wins do not guarantee near-term sales. CEO Chris Allexandre and CFO Tonya Stevens will discuss results May 5.
Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

Eaton Stock Faces May 5 Test as AI Data Center Bets Meet Earnings Reality

4 May 2026
Eaton will report first-quarter results before the NYSE opens Tuesday, following its Boyd Thermal acquisition and push into AI data-center power systems. Shares closed Friday at $425.55, down 1.72%, with a market value near $166 billion. Wall Street expects adjusted earnings of $2.75 per share for the March quarter. Investors are watching for signs that AI data-center demand is driving orders and profit.
Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

Blue Owl Capital Faces Fresh Private-Credit Test After Brown Slashes OBDC Stake

4 May 2026
Brown University cut its stake in Blue Owl Capital Corp’s main private-credit fund by 53%, holding 1.5 million OBDC shares at March 31, down from 3.2 million at the end of 2025. Blue Owl’s quarterly filing showed revenue rose to $753.8 million, net income doubled to $15.5 million, but its direct-lending strategy posted a 1.1% net loss as repayments outpaced new loans.
Go toTop